3rd December 2019: Metrion Biosciences and LifeArc extend ion channel drug discovery collaboration to accelerate neuroscience-focused research
8th April 2019: Metrion Biosciences appoints Dr Andrew Southan as Chief Executive Officer
1st April 2019: Metrion Biosciences closes funding round
29th January 2019: Metrion Biosciences and LifeArc sign collaboration agreement for neuroscience-focused ion channel drug discovery.